CINECA IRIS Institutional Research Information System

MICCOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.463
EU - Europa 5.958
AS - Asia 2.058
AF - Africa 175
SA - Sud America 29
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.003
IT - Italia 2.287
SE - Svezia 1.116
CN - Cina 1.099
BG - Bulgaria 630
CA - Canada 446
DE - Germania 437
UA - Ucraina 373
GB - Regno Unito 301
FI - Finlandia 279
SG - Singapore 264
TR - Turchia 246
VN - Vietnam 236
CH - Svizzera 169
FR - Francia 86
CI - Costa d'Avorio 81
IN - India 78
AT - Austria 76
HK - Hong Kong 74
RU - Federazione Russa 70
SN - Senegal 44
BE - Belgio 43
NG - Nigeria 36
NL - Olanda 15
IE - Irlanda 11
MX - Messico 11
JP - Giappone 10
AU - Australia 9
NZ - Nuova Zelanda 9
PL - Polonia 9
IL - Israele 8
BJ - Benin 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
ES - Italia 6
GR - Grecia 6
HU - Ungheria 6
RO - Romania 6
AR - Argentina 5
BR - Brasile 5
IR - Iran 5
PE - Perù 5
BO - Bolivia 4
EG - Egitto 4
KR - Corea 4
NP - Nepal 4
PK - Pakistan 4
SA - Arabia Saudita 4
CL - Cile 3
EC - Ecuador 3
EU - Europa 3
HR - Croazia 3
LK - Sri Lanka 3
MY - Malesia 3
NO - Norvegia 3
PT - Portogallo 3
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
ID - Indonesia 2
KZ - Kazakistan 2
LT - Lituania 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
VE - Venezuela 2
A1 - Anonimo 1
BD - Bangladesh 1
BZ - Belize 1
EE - Estonia 1
GH - Ghana 1
GL - Groenlandia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
MO - Macao, regione amministrativa speciale della Cina 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 21.705
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.767
Ann Arbor 1.536
Fairfield 1.254
Chandler 1.205
Houston 1.154
Milan 853
Ashburn 721
Sofia 628
Seattle 574
Jacksonville 526
Wilmington 455
Ottawa 428
Beijing 402
Cambridge 395
New York 371
Boardman 266
Princeton 266
Lawrence 239
Izmir 235
Nanjing 205
Medford 199
Des Moines 176
Bern 165
Serra 160
Dearborn 147
Singapore 131
Dong Ket 97
Jüchen 90
Rome 84
Abidjan 81
Florence 78
Nanchang 78
San Diego 70
Hong Kong 68
Vienna 65
Falls Church 62
Boulder 54
Redwood City 54
Kunming 46
Lancaster 46
Marseille 46
Pisa 46
Dakar 44
Brussels 43
Tianjin 43
Bremen 42
Los Angeles 42
Frankfurt am Main 41
Pune 37
Shenyang 36
Lagos 35
Jiaxing 34
Hebei 32
Changsha 31
Hefei 26
Ogden 26
Verona 25
Manchester 21
Norwalk 21
Lanzhou 20
Orange 20
Washington 20
Auburn Hills 19
Hangzhou 17
London 17
Naples 16
Jinan 15
Helsinki 14
Nürnberg 14
Phoenix 14
San Francisco 14
Chengdu 10
Genzano di Roma 10
Indiana 10
Guangzhou 9
Walnut 9
Cava Dei Tirreni 8
Chicago 8
Edinburgh 8
Leicester 8
Warsaw 8
Changchun 7
Chennai 7
Cotonou 7
Fuzhou 7
Sligo 7
Turin 7
Budapest 6
Copenhagen 6
Dallas 6
Detroit 6
Redmond 6
Castelfranco Veneto 5
Catania 5
Christchurch 5
Council Bluffs 5
Kettering 5
Lima 5
Lucca 5
Melbourne 5
Totale 16.502
Salva come PNG Salva come JPEG
Nome #
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 407
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 173
Lipoprotein Glomerulopathy: Molecular Characterization of Three Italian Patients and Literature Survey 164
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 158
Prevalence and risk factors for gestational diabetes assessed by universal screening 153
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants 153
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients:the EURODIAB Prospective Complications Study 143
null 142
Early detection of left ventricular dysfunction in diabetes mellitus patients with normal ejection fraction, stratified by BMI: A preliminary speckle tracking echocardiography study 142
Valutazione dell'asse ipotalamo-ipofisi-gonadi nel maschio diabetico. 138
Relationship between total cholesterol level and impairment of intrinsic myocardial contractility, strain and of the active phase of relaxation EUROPEAN HEART JOURNAL AUG 2006 VL 27 SU Suppl. 1 BP 405 EP 406 134
QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. 134
Prognostic implications of diabetes phenotyping: new concepts for an old disease 133
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance 132
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 132
Cardiovascular disease and its risk factors in IDDM in Europe 132
Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus. 132
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 131
Short-term vs. overnight urine collection for screening of urinary albumin excretion rate. 129
Diabetes programme facts and figures 127
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The Eurodiab Prospective Complications Study(PCS) 126
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 126
C-reactive protein and metabolic syndrome in women with previous gestational diabetes 124
Insulin Resistance and Lipid Disorders 124
null 124
Microvascular and acute complications in insulin dependent diabetes mellitus: the EURODIAB IDDM Complications Study 122
Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome 122
Protein intake and urinary albumin excretion rates in the EURODIAB IDDM complications study 121
BLOOD-PRESSURE, RETINOPATHY AND URINARY ALBUMIN EXCRETION IN IDDM - THE EURODIAB IDDM COMPLICATIONS STUDY 121
Nutritional intake of 2868 IDDM patients from 30 centres in Europe 120
null 120
CLINICAL AND METABOLIC EFFECTS OF A PILL CONTAINING 30 MCG ETHINYLESTRADIOL PLUS 75 MCG GESTODENE 119
THE RELATIONSHIP BETWEEN SMOKING AND MICROVASCULAR COMPLICATIONS IN THE EURODIAB IDDM COMPLICATIONS STUDY 119
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 119
Repeatability of three-day dietary records in the EURODIAB IDDM complications study 118
Endothelial progenitor cells and endothelial dysfunction in prediabetic and newly diagnosed type 2 diabetic subjects 117
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment 117
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study 116
PRAVASTATIN VS GEMFIBROZIL IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - THE ITALIAN MULTICENTER PRAVASTATIN STUDY-I 115
null 115
Radiofrequency-based estimates of local common carotid stiffness and intima-media thickness: implications for detecting early vascular involvement in hypertension and diabetes 114
Intermediate metabolism in normal pregnancy and in gestational diabetes 114
Effects of guar-pasta on serum lipid levels in obese diabetic and non-diabetic women with normal lipids. 113
Basal insulin and cardiovascular and other outcomes in dysglycemia 113
null 112
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 112
Genetically determined absence of HDL-cholesterol and coronary atherosclerosis 111
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes 111
Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM 111
PREVALENCE AND TYPE OF SEXUAL DYSFUNCTIONS IN DIABETIC MALES - A STANDARDIZED CLINICAL APPROACH 110
A natural apolipoprotein A-I variant, apoA-I(L141R)(Pisa), interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta(1)-HDL and influences efflux of cholesterol into plasma 110
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus 110
An optimized method to measure glycosylproteins: HPLC assay of 5-hydroxymethil-2-furfuraldehyde (5-HMF). 109
Which method for 'microalbuminuria' in diabetes mellitus? 109
Divergent changes in expression of antioxidant enzymes in human EPCs and HUVECs exposed to high glucose 109
Coronary artery disease and stroke in type 2 diabetic patients: possible role of a raised central pulse pressure 109
MICROALBUMINURIA IN TYPE-I (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT RETINOPATHY 108
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 108
null 108
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. 107
Valutazione del grado di conoscenza basale della malattia diabetica in pazienti ambulatoriali. 105
Human EPCs and HUVECs exposed to high glucose: expression of antioxidative enzymes 105
Prevalence of the metabolic syndrome among Italian adults according to ATP III definition 105
Guar-pasta: a new diet for obese subjects? 105
CLINICAL AND METABOLIC STUDY OF A NEW PILL CONTAINING 20 MCG ETHINYLESTRADIOL PLUS 0.150 MG DESOGESTREL 104
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study 104
Basal insulin kinetics and glucose-stimulated secretion in untreated and treated diabetic patients and in normal subjects. 103
The Metabolic Syndrome 103
Dietary habits in type 2 diabetes mellitus: how is adherence to dietary recommendations? 103
Hyperglycaemia and cardiovascular risk 103
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 103
Diabete e disturbi dell'attivita' sessuale 102
Capitolo 1: Atorvastatina: proprietà farmacologiche ed impiego clinico 102
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 102
Primary Prevention of Cardiovascular Disease in People With Dysglycemia 102
Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)(Pisa), and an apolipoprotein A-I null allele in patients with absence of HDL, cholesterol, corneal opacifications, and coronary heart disease 102
null 102
Microalbuminuria is linked with abnormalities favoring atherosclerosis in type 2 diabetics. 102
EFFECTS OF PANTETHINE ON LIPIDS AND APOLIPOPROTEINS IN HYPERCHOLESTEROLEMIC DIABETIC AND NON DIABETIC-PATIENTS 101
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance 101
Optimal therapy of type 2 diabetes: a controversial challenge 101
The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy 100
Under-treatment of migrants with diabetes in a universalistic health care system: the ARNO Observatory. 100
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes 100
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study 99
Factitious hypoglycemia in an insulin-dependent woman in the eighth week of gestation 99
Enzimuria e tubulopatia diabetica: più di un semplice sospetto. 98
Multidrug treatment of type 2 diabetes: a challenge for compliance 98
Early Systolic dysfunction in asymptomatic type 1 diabetic patients DIABETES JUN 2006 VL 55 SU Suppl. 1 BP A153 EP A153 97
Pharmacological intervention in prediabetes: considering the risks and benefits 97
null 97
Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial 96
Early impairment of ß-cell function characterizes normotolerant Caucasian women with previous gestational diabetes 96
Fibrinogen and von Willebrand factor in IDDM: Relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: The EURODIAB IDDM complications study 96
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes 96
Blood glucose control and coronary heart disease 96
Serum gamma-glutamyltransferase is not associated to peripheral arterial disease in type 2 diabetic patients: Cross-sectional findings 96
null 96
null 96
Diabete ed educazione: ruolo ed utilità clinica dell'educazione formale 95
Totale 11.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.877 0 0 199 223 350 394 418 284 381 234 311 83
2020/20211.848 186 93 165 71 222 75 144 183 134 163 104 308
2021/20222.724 26 171 53 178 563 361 77 130 153 74 161 777
2022/20233.310 447 383 181 325 402 466 45 257 515 20 222 47
2023/20242.917 463 318 405 208 440 468 77 112 61 70 77 218
2024/2025381 42 311 28 0 0 0 0 0 0 0 0 0
Totale 21.967